Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("OREMUS, Mark")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

Female specialists were more likely to respond to a postal questionnaire about drug treatments for Alzheimer diseaseOREMUS, Mark; WOLFSON, Christina.Journal of clinical epidemiology. 2004, Vol 57, Num 6, pp 620-623, issn 0895-4356, 4 p.Article

A Systematic Review to Assess the Policy-Making Relevance of Dementia Cost-of-Illness Studies in the US and CanadaOREMUS, Mark; CAROLINA AGUILAR, S.PharmacoEconomics (Auckland). 2011, Vol 29, Num 2, pp 141-156, issn 1170-7690, 16 p.Article

A hybrid qualitative method for pretesting questionnaires : The example of a questionnaire to caregivers of Alzheimer disease patientsOREMUS, Mark; COSBY, Jarold L; WOLFSON, Christina et al.Research in nursing & health. 2005, Vol 28, Num 5, pp 419-430, issn 0160-6891, 12 p.Article

Review of outcome measurement instruments in Alzheimer's disease drug trials : Introduction : Alzheimer's disease drug trialsDEMERS, Louise; OREMUS, Mark; PERRAULT, Anne et al.Journal of geriatric psychiatry and neurology. 2000, Vol 13, Num 4, pp 161-169, issn 0891-9887Article

Review of outcome measurement instruments in Alzheimer's disease drug trials : Psychometric properties of Global scales : Alzheimer's disease drug trialsOREMUS, Mark; PERRAULT, Anne; DEMERS, Louise et al.Journal of geriatric psychiatry and neurology. 2000, Vol 13, Num 4, pp 197-205, issn 0891-9887Article

Review of outcome measurement instruments in Alzheimer's disease drug trials : Psychometric properties of functional and quality of Life scales : Alzheimer's disease drug trialsDEMERS, Louise; OREMUS, Mark; PERRAULT, Anne et al.Journal of geriatric psychiatry and neurology. 2000, Vol 13, Num 4, pp 170-180, issn 0891-9887Article

Review of outcome measurement instruments in Alzheimer's disease drug trials : Psychometric properties of behavior and Mood scales : Alzheimer's disease drug trialsPERRAULT, Anne; OREMUS, Mark; DEMERS, Louise et al.Journal of geriatric psychiatry and neurology. 2000, Vol 13, Num 4, pp 181-196, issn 0891-9887Article

Health Utility Scores in Alzheimer's Disease: Differences Based on Calculation With American and Canadian Preference WeightsOREMUS, Mark; TARRIDE, Jean-Eric; CLAYTON, Natasha et al.Value in health. 2014, Vol 17, Num 1, pp 77-83, issn 1098-3015, 7 p.Article

Systematic reviews identify important methodological flaws in stroke rehabilitation therapy primary studies: review of reviewsSANTAGUIDA, Pasqualina; OREMUS, Mark; WALKER, Kathryn et al.Journal of clinical epidemiology. 2012, Vol 65, Num 4, pp 358-367, issn 0895-4356, 10 p.Article

Observational studies in systemic reviews of comparative effectiveness: AHRQ and the Effective Health Care Program : AHRQ Series Part II: Methods Guide for Comparative EffectivenessNORRIS, Susan L; ATKINS, David; SCHOELLES, Karen et al.Journal of clinical epidemiology. 2011, Vol 64, Num 11, pp 1178-1186, issn 0895-4356, 9 p.Article

Identification of myocardial injury in the emergency settingKAVSAK, Peter A; WORSTER, Andrew; YOU, John J et al.Clinical biochemistry. 2010, Vol 43, Num 6, pp 539-544, issn 0009-9120, 6 p.Article

Studies of stroke rehabilitation therapies should report blinding and rationalize use of outcome measurement instrumentsOREMUS, Mark; SANTAGUIDA, Pasqualina; WALKER, Kathryn et al.Journal of clinical epidemiology. 2012, Vol 65, Num 4, pp 368-374, issn 0895-4356, 7 p.Article

The General Public's Willingness to Pay for Tax Increases to Support Unrestricted Access to an Alzheimer's Disease MedicationOREMUS, Mark; TARRIDE, Jean-Eric; RAINA, Parminder et al.PharmacoEconomics (Auckland). 2012, Vol 30, Num 11, pp 1085-1095, issn 1170-7690, 11 p.Article

Multiplex protein assay performance/evaluation and the requirement for precision and correlation to clinical assaysPHAN, Kim; SOHN, Kun-Young; HILL, Stephen A et al.Clinical chemistry and laboratory medicine. 2011, Vol 49, Num 11, pp 1915-1918, issn 1434-6621, 4 p.Article

A systematic review of heparin to treat burn injuryOREMUS, Mark; HANSON, Mark D; WHITLOCK, Richard et al.Journal of burn care & research. 2007, Vol 28, Num 6, pp 794-804, issn 1559-047X, 11 p.Article

Interrater reliability of the modified Jadad Quality Scale for systematic reviews of Alzheimer's disease drug trialsOREMUS, Mark; WOLFSON, Christina; PERRAULT, Anne et al.Dementia and geriatric cognitive disorders. 2001, Vol 12, Num 3, pp 232-236, issn 1420-8008Article

Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program : AHRQ Series Part II: Methods Guide for Comparative EffectivenessRONGWEI FU; GARTLEHNER, Gerald; SANTAGUIDA, Pasqualina et al.Journal of clinical epidemiology. 2011, Vol 64, Num 11, pp 1187-1197, issn 0895-4356, 11 p.Article

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia : Evidence Review for a Clinical Practice GuidelineRAINA, Parminder; SANTAGUIDA, Pasqualina; ISMAILA, Afisi et al.Annals of internal medicine. 2008, Vol 148, Num 5, pp 379-397, issn 0003-4819, 19 p.Article

Donepezil and rivastigmine in the treatment of Alzheimer's disease: A best-evidence synthesis of the published data on their efficacy and cost-effectivenessWOLFSON, Christina; OREMUS, Mark; SHUKLA, Vijay et al.Clinical therapeutics. 2002, Vol 24, Num 6, pp 862-886, issn 0149-2918Article

  • Page / 1